title: Words of Wisdom. Re: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
authors: Department of Urology, Eberhard Karls University, Tübingen, Germany.
authors: Jens
authors: J
authors: Bedke
authors: Department of Urology, Eberhard Karls University, Tübingen, Germany. Electronic address: Urologie@med.uni-tuebingen.de.
authors: Arnulf
authors: A
authors: Stenzl
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D020123:Sirolimus / Q000031:analogs & derivatives*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D020123:Sirolimus